Please login to the form below

Not currently logged in
Email:
Password:

mouth cancer

This page shows the latest mouth cancer news and features for those working in and with pharma, biotech and healthcare.

NICE set to reject Merck’s Erbitux for head and neck cancer

NICE set to reject Merck’s Erbitux for head and neck cancer

Merck has since provided further evidence for Erbitux to assist this appraisal process, reducing the indication to patients with mouth cancer alone as well as proposing an additional, undisclosed discount. ... However, the committee said that the new

Latest news

  • UK's Change4Life health programme launches drinks tracker app UK's Change4Life health programme launches drinks tracker app

    Aside from the link with liver disease and pancreatitis, regular consumption of two large glasses of wine or two pints of strong lager a day could increase the occurrence of mouth ... cancer three-fold.

  • PR and Med Ed news in brief

    Dental campaign success. Mouth Cancer Awareness Week 2004 was the most successful mouth cancer campaign ever said the British Dental Health Foundation.

  • Ethnic Minority Cancer Awareness Week

    Sir Trevor McDonald is backing a campaign to raise levels of awareness about the affects of cancer on Black and Minority Ethnic (BME) communities. ... of mouth cancer and Bangladeshi and Chinese communities having a higher incidence of liver cancer.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics